0 Évaluations
ID

14241

Description

Efficacy of Ciclesonide and Fluticasone Propionate in Adult Patients With Moderate and Severe Persistent Asthma (18 to 75 y) (BY9010/IT-101); ODM derived from: https://clinicaltrials.gov/show/NCT00163319

Lien

https://clinicaltrials.gov/show/NCT00163319

Mots-clés

Versions (2)
  1. 04/04/2016 04/04/2016 -
  2. 05/04/2016 05/04/2016 -
Téléchargé le

5 avril 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

  • Plus récent
  • Plus ancien
  • Favori
  • Plus récent
    • Plus récent
    • Plus ancien
    • Favori

    Aucun commentaire

    Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

    Eligibility Asthma NCT00163319

    Anglais

    Eligibility Asthma NCT00163319

    1 Formulaires  
    1. StudyEvent: Eligibility
      1. Eligibility Asthma NCT00163319
    Criteria
    Description

    Criteria

    written informed consent
    Description

    written informed consent

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0021430
    history of bronchial asthma for at least 6 months
    Description

    asthma

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0004096
    UMLS CUI [1,2]
    C0040223
    pre-treatment with cfc-beclomethasone dipropionate (cfc-bdp) ≥ 1000 mcg/day or equivalent and a long-acting beta agonist (laba) either in free or fixed combination
    Description

    cfc-beclomethasone dipropionate and a long-acting beta agonist

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0004906
    UMLS CUI [2]
    C2936789
    fev1 ≥ 80% of predicted
    Description

    fev1

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0748133
    Exclusion criteria
    Description

    Exclusion criteria

    Alias
    UMLS CUI-1
    C0680251
    concomitant severe diseases or diseases which are contraindications for the use of inhaled steroids or contraindications for the use of labas
    Description

    comorbidity limiting inhaled steroids

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C2065041
    UMLS CUI [1,2]
    C0439801
    UMLS CUI [1,3]
    C0009488
    UMLS CUI [2,1]
    C2936789
    UMLS CUI [2,2]
    C0439801
    UMLS CUI [2,3]
    C0009488
    copd
    Description

    copd

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0024117
    smoking with ≥10 pack-years
    Description

    pack years

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C1277691
    pregnancy
    Description

    pregnancy

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0032961
    intention to become pregnant during the course of the study
    Description

    intention to become pregnant

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0032961
    UMLS CUI [1,2]
    C1283828
    breast feeding
    Description

    breast feeding

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0006147
    lack of safe contraception
    Description

    lack of safe contraception

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0700589
    UMLS CUI [1,2]
    C0332197
    Retour au début de la page

    Similar models

    Eligibility Asthma NCT00163319

    1 Formulaires
    1. StudyEvent: Eligibility
      1. Eligibility Asthma NCT00163319
    Name
    Type
    Description | Question | Decode (Coded Value)
    Type de données
    Alias
    Item Group
    written informed consent
    Item
    written informed consent
    boolean
    C0021430 (UMLS CUI [1])
    asthma
    Item
    history of bronchial asthma for at least 6 months
    boolean
    C0004096 (UMLS CUI [1,1])
    C0040223 (UMLS CUI [1,2])
    cfc-beclomethasone dipropionate and a long-acting beta agonist
    Item
    pre-treatment with cfc-beclomethasone dipropionate (cfc-bdp) ≥ 1000 mcg/day or equivalent and a long-acting beta agonist (laba) either in free or fixed combination
    boolean
    C0004906 (UMLS CUI [1])
    C2936789 (UMLS CUI [2])
    fev1
    Item
    fev1 ≥ 80% of predicted
    boolean
    C0748133 (UMLS CUI [1])
    Item Group
    Exclusion criteria
    C0680251 (UMLS CUI-1)
    comorbidity limiting inhaled steroids
    Item
    concomitant severe diseases or diseases which are contraindications for the use of inhaled steroids or contraindications for the use of labas
    boolean
    C2065041 (UMLS CUI [1,1])
    C0439801 (UMLS CUI [1,2])
    C0009488 (UMLS CUI [1,3])
    C2936789 (UMLS CUI [2,1])
    C0439801 (UMLS CUI [2,2])
    C0009488 (UMLS CUI [2,3])
    copd
    Item
    copd
    boolean
    C0024117 (UMLS CUI [1])
    pack years
    Item
    smoking with ≥10 pack-years
    boolean
    C1277691 (UMLS CUI [1])
    pregnancy
    Item
    pregnancy
    boolean
    C0032961 (UMLS CUI [1])
    intention to become pregnant
    Item
    intention to become pregnant during the course of the study
    boolean
    C0032961 (UMLS CUI [1,1])
    C1283828 (UMLS CUI [1,2])
    breast feeding
    Item
    breast feeding
    boolean
    C0006147 (UMLS CUI [1])
    lack of safe contraception
    Item
    lack of safe contraception
    boolean
    C0700589 (UMLS CUI [1,1])
    C0332197 (UMLS CUI [1,2])
    Retour au début de la page 

    Aide

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial